HARP: Bathi resik saben saham (EPS TTM) Harpoon Tx

Integration into the Merck structure at a premium and the success of the TriTAC platform in treating lung cancer define the financial profile of Harpoon Therapeutics (HARP). The change in the rolling annual EPS clearly demonstrates this trend, where -8.74 becomes the new value for the indicator. A stable liquidity reserve supports the development of targeted drugs, although geopolitical tensions and sanctions complicate the logistics of biomaterials, slowing down global certification.

HARP Bathi resik saben saham sajrone 12 wulan pungkasan Harpoon Therapeutics (04.07.2022 - 16.03.2024)

Ringkesan rincian data analitis Harpoon Therapeutics Corp (HARP)

- rega saham lan prakiraan rega para ahli:

Kutipan saham Harpoon Therapeutics, Inc.|HARP - Konsensus nilai wajar

- informasi kapitalisasi pasar:

Kapitalisasi pasar Harpoon Therapeutics|HARP - Rega Tumbas Perusahaan

- rincian valuasi buku bisnis:

Aset Bersih saben Siji Saham Harpoon Therapeutics|HARP - Aset Bersih Perusahaan|Rasio Nilai Pasar marang Nilai Buku harpoontx.com|HARP - Gunggung Aset Perusahaan

- indikator beban kredit lan likuiditas emiten:

Rasio Total Utang marang Ekuitas Harpoon Therapeutics|HARP - Utang jangka dawa marang modal|Utang jangka cendhak marang ekuitas Harpoon Therapeutics, Inc.|HARP - Utang agregat perusahaan|Rasio utang marang kapitalisasi buku Harpoon Therapeutics, Inc.|HARP - Utang jangka dawa|Kewajiban jangka cendhak perusahaan Harpoon Therapeutics|Indikator likuiditas cepet harpoontx.com

- data bathi lan kelipatan valuasi:

HARP - Bathi sawise mbayar pajeg|Proyeksi bathi mangsa ngarep Harpoon Therapeutics|HARP - Nilai perusahaan marang bathi resik|Pangali Forward P/E harpoontx.com|HARP - Rega marang bathi kanthi panyesuaian wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Harpoon Therapeutics Corp|HARP - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi resik saben saham (EPS TTM) Harpoon Therapeutics|HARP - Bathi resik saben saham (EPS TTM)|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan harpoontx.com|HARP - Dinamika bathi saben saham ing taun lumaku|Prakiraan wutah bathi saben saham kanggo taun ngarep Harpoon Therapeutics

- rincian pendapatan lan dodolan:

HARP - Total pendapatan perusahaan|Prakiraan volume dodolan Harpoon Therapeutics, Inc.|HARP - Rasio kapitalisasi pasar marang pendapatan|Multiplikator Forward P/S Harpoon Therapeutics Inc|HARP - Wutah dodolan YoY (TTM)

Pambiji fundamental:HARP - Harpoon Therapeutics Corp

Amidst fierce competition for patients and patent wars within the T-cell immunotherapy sector, this metric allows for an assessment of the financial stability of Harpoon Therapeutics (HARP). Net income per share over the last four quarters is calculated by dividing the total annual net income by the number of securities. This indicator demonstrates the actual efficiency of the business, stripped of the impact of issuance. Positive dynamics confirm management's ability to withstand the expansion of mRNA therapy, while a decline in the indicator signals a risk of capital freeze.

Pesaing utama